Search by Drug Name or NDC

NDC 51655-0432-52 Alfuzosin Hydrochloride 10 mg/1 Details

Alfuzosin Hydrochloride 10 mg/1

Alfuzosin Hydrochloride is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals, LLC. The primary component is ALFUZOSIN HYDROCHLORIDE.

MedlinePlus Drug Summary

Alfuzosin is used in men to treat symptoms of an enlarged prostate (benign prostatic hyperplasia or BPH), which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency. Alfuzosin is in a class of medications called alpha blockers. It works by relaxing the muscles in the prostate and bladder to allow urine to flow more easily.

Related Packages: 51655-0432-52
Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Alfuzosin

Product Information

NDC	51655-0432
Product ID	51655-432_f2f42c98-4119-5f70-e053-2a95a90add02
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Alfuzosin Hydrochloride
Proprietary Name Suffix	n/a
Non-Proprietary Name	Alfuzosin Hydrochloride
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	10
Active Ingredient Units	mg/1
Substance Name	ALFUZOSIN HYDROCHLORIDE
Labeler Name	Northwind Pharmaceuticals, LLC
Pharmaceutical Class	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA079057
Listing Certified Through	2024-12-31

Package

NDC 51655-0432-52 (51655043252)

Pricing Information	N/A
NDC Package Code	51655-432-52
Billing NDC	51655043252
Package	30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-432-52)
Marketing Start Date	2020-09-09
NDC Exclude Flag	N